NAMS takes stand on testosterone for postmenopausal women

Article

While some research has shown testosterone therapy can improve sexual desire, arousal, and orgasmic response in postmenopausal women, The North American Menopause Society (NAMS), in a recent position statement, advises practitioners to proceed with caution.

While some research has shown testosterone therapy can improve sexual desire, arousal, and orgasmic response in postmenopausal women, The North American Menopause Society (NAMS), in a recent position statement, advises practitioners to proceed with caution.

They advocate first evaluating other causes of sexual dysfunction, including stress, fatigue, relationship conflict, depression, anxiety, vaginal atrophy, hypothyroidism, and drug use. They also stress that the association between low testosterone and sexual dysfunction is still somewhat tenuous. Hence, the lowest possible dose of testosterone for the shortest period of time should be used to achieve treatment goals. Products designed for men generally should not be used for women unless doses are reduced considerably and blood levels are monitored.

NAMS also reminds clinicians that while patches or topical agents may be preferred to oral preparations, only oral and intramuscular versions are currently government-approved for use in women. Finally, lab testing of testosterone levels should be used only to monitor testosterone levels during therapy and not to diagnose testosterone insufficiency; currently available tests cannot accurately detect the low values typically found in postmenopausal women.

Related Videos
Study unveils maternal mortality tracking trends | Image Credit: obhg.com
How Harmonia Healthcare is revolutionizing hyperemesis gravidarum care | Image Credit: hyperemesis.org
Unveiling gender disparities in medicine | Image Credit:  findcare.ahn.org.
Exploring the intersection of heart health and women's health | Image Credit: cedars-sinai.org
Unlocking the benefits of DHEA | Image Credit: drannacabeca.com
Unlocking the power of oxytocin | Image credit: drannacabeca.com
Revolutionizing menopause management: A deep dive into fezolinetant | Image Credit: uvahealth.com.
© 2024 MJH Life Sciences

All rights reserved.